Discover the booming Interventional Pulmonary Disease (IPD) market for COPD. This comprehensive analysis reveals a $2.5B market in 2025, projected to reach $4.5B by 2033, driven by technological advancements and rising COPD prevalence. Explore market trends, segmentation, key players (Pulmonx, Olympus, Boston Scientific), and regional growth forecasts.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.